The key point is from a regulatory point of view, nothing has changed, we just need to get this litigation sorted out and move on.

Liam Condon

Categorized in : Health News

The experience has been in all industries (involved in litigation), these things always get solved, there has been a significant overreaction there and it's a great buying opportunity. It's almost like buy one, get one free.

We expect sales in Brazil to grow this year and next year. by Liam Condon

We expect sales in Brazil to grow this year and next year.

Everything that comes tends to be selective in nature. There won't be a new glyphosate. That was probably a once-in-a-lifetime product.

I'm not concerned in terms of damping sales because we don't define ourselves as a volume seller. We rather offer a prescription for a weed-free field, and we get paid based on the quality of the outcome.

If our only goal is to sell as much inputs as possible by the liters of chemicals, I think we would have a real problem going forward.

If our only goal is to sell as much inputs as possible by the litres of chemicals, I think we would have a real problem going forward.